| dc.contributor.author | Sertkaya, Zülfü | |
| dc.date.accessioned | 10.07.201910:49:13 | |
| dc.date.accessioned | 2019-07-10T20:04:25Z | |
| dc.date.available | 10.07.201910:49:13 | |
| dc.date.available | 2019-07-10T20:04:25Z | |
| dc.date.issued | 2016 | en_US |
| dc.identifier.citation | Sertkaya, Z. (2016). Re: Fascelli et al: Combined biparametric prostate magnetic resonance ımaging and prostate-specific antigen in the detection of prostate cancer: A validation study in a biopsy-naive patient population (urology 2016; 88:125-134). Urology, 95, 223-223. https://dx.doi.org/10.1016/j.urology.2016.04.011. | |
| dc.identifier.issn | 0090-4295 | |
| dc.identifier.issn | 1527-9995 | |
| dc.identifier.uri | https://dx.doi.org/10.1016/j.urology.2016.04.011 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/4048 | |
| dc.description | WOS: 000383698300057 | en_US |
| dc.description | PubMed ID: 27112511 | en_US |
| dc.description.abstract | I read with interest the article by Fascelli et al1The authorsaimed to validate the use of biparametric (T2- and diffusion-weighted) magnetic resonance imaging and prostate-specific antigen (PSA) or PSA density in a biopsy-naivecohort at risk for prostate cancer (PCa) and they used for-mulas for validation. | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Elsevier Science Inc | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Mortality | en_US |
| dc.subject | Biparametric | en_US |
| dc.subject | Prostate | en_US |
| dc.title | Re: Fascelli et al: Combined biparametric prostate magnetic resonance ımaging and prostate-specific antigen in the detection of prostate cancer: A validation study in a biopsy-naive patient population (urology 2016; 88:125-134) | en_US |
| dc.type | letter | en_US |
| dc.relation.ispartof | Urology | en_US |
| dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalı | en_US |
| dc.identifier.volume | 95 | en_US |
| dc.identifier.startpage | 223 | en_US |
| dc.identifier.endpage | 223 | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
| dc.identifier.doi | 10.1016/j.urology.2016.04.011 | en_US |
| dc.identifier.wosquality | Q3 | en_US |
| dc.identifier.scopusquality | Q1 | en_US |
